Neuroptics, based in Irvine, CA, is a leading developer and marketer of innovative technology for critical care medicine, neurology, emergency medicine, ophthalmology, and research. Their pupillometers provide accurate, reliable, and objective pupil size and reactivity data to assist in detecting cerebral insult, guiding treatment, and informing prognosis.
With their advanced pupillometry systems like the NPI 300, Neuroptics is dedicated to helping clinicians improve patient outcomes worldwide. Their devices are widely adopted in hospitals across the U.S. and have revolutionized the way critical care patients are assessed and managed.
Generated from the website